CIBC World Market’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Hold |
16,335
| – | – | ﹤0.01% | 969 |
|
|
2025
Q1 | $548K | Sell |
16,335
-3,500
| -18% | -$117K | ﹤0.01% | 930 |
|
|
2024
Q4 | $778K | Hold |
19,835
| – | – | ﹤0.01% | 857 |
|
|
2024
Q3 | $781K | Sell |
19,835
-16,550
| -45% | -$652K | ﹤0.01% | 797 |
|
|
2024
Q2 | $1.42M | Sell |
36,385
-935
| -3% | -$36.5K | ﹤0.01% | 661 |
|
|
2024
Q1 | $1.61M | Sell |
37,320
-572
| -2% | -$24.6K | ﹤0.01% | 635 |
|
|
2023
Q4 | $1.75M | Sell |
37,892
-7,480
| -16% | -$344K | ﹤0.01% | 565 |
|
|
2023
Q3 | $1.55M | Buy |
45,372
+4,150
| +10% | +$142K | 0.01% | 557 |
|
|
2023
Q2 | $1.59M | Buy |
41,222
+8,473
| +26% | +$326K | 0.01% | 582 |
|
|
2023
Q1 | $1.17M | Buy |
32,749
+10,199
| +45% | +$365K | ﹤0.01% | 643 |
|
|
2022
Q4 | $889K | Sell |
22,550
-750
| -3% | -$29.6K | ﹤0.01% | 692 |
|
|
2022
Q3 | $841K | Sell |
23,300
-23,587
| -50% | -$851K | ﹤0.01% | 675 |
|
|
2022
Q2 | $1.43M | Buy |
46,887
+5,550
| +13% | +$169K | 0.01% | 574 |
|
|
2022
Q1 | $1.26M | Sell |
41,337
-8,297
| -17% | -$254K | ﹤0.01% | 646 |
|
|
2021
Q4 | $1.55M | Buy |
+49,634
| New | +$1.55M | ﹤0.01% | 607 |
|